Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nalbuphine on the median effective dose of sufentanil for postoperative analgesia
ChiCTR1800014603Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and sufentanil in postoperative pain (4 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Visual analogue scale pain score, Observer's Assessment of Alertness/Sedation score and 2 more. Started Feb 2018; status: recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800014603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014603.